Ulf Staginnus, is the creator of HealthEconomics Blog and Head Pricing, Health Economics & Outcome Research, Europe, at Novartis Oncology. He talks about the direct implications of recent European cost-containment measures on the pharmaceutical industry. Watch, and learn why the tough times are here to stay. what industry executives and policy makers alike, must do to reach an innovative and cost-effective agreement.
You are here: / / Interview – Ulf Staginnus on European Cost-Containment Measures and Effects on Healthcare